1,3-DIBROMO-2-BROMOMETHYL-2-[6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE-1-YL-METHYL]-PROPANE
Compound with spectra: 1 NMR
![1,3-DIBROMO-2-BROMOMETHYL-2-[6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE-1-YL-METHYL]-PROPANE](/api/compound/I5ChO3XKBY0.png?ph=true&h=300&w=458 "1,3-DIBROMO-2-BROMOMETHYL-2-[6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE-1-YL-METHYL]-PROPANE")
| SpectraBase Compound ID | I5ChO3XKBY0 |
|---|---|
| InChI | InChI=1S/C25H35Br3N4O/c1-4-31(5-2)24(33)29-18-10-20-19-7-6-8-21-23(19)17(9-22(20)30(3)12-18)11-32(21)16-25(13-26,14-27)15-28/h6-8,11,18,20,22H,4-5,9-10,12-16H2,1-3H3,(H,29,33)/t18-,20+,22+/m0/s1 |
| InChIKey | FTWXVVMOSLJGHA-CZTZKLFOSA-N |
| Mol Weight | 647.3 g/mol |
| Molecular Formula | C25H35Br3N4O |
| Exact Mass | 644.036101 g/mol |
| Enantiomer InChIKey | FTWXVVMOSLJGHA-CBQOVEMMSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
1,3-DIBROMO-2,2-DI-[6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE-1-YL-METHYL]-PROPANE
#5C;BROMO-2,2-DI-[6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE-1-YL-METHYL]-3-[6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE-1-YL]-PROPANE
1-(6-BROMOHEXYL)-6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE
1,6-DI-[6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE-1-YL]-HEXANE
1-ALLYL-6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE
1,4-DI-[6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE-1-YL-METHYL]-BENZENE
1-(2-AMINOETHYL)-6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE
1,3-DI-[6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE-1-YL-METHYL]-BENZENE
1-CARBOXYMETHYL-6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE
DI-[6-METHYL-8-ALPHA-(DIETHYLCARBAMOYLAMINO)-ERGOLINE-1-YL]-METHANE
| Title | Journal or Book | Year |
|---|---|---|
| Clustered ergot alkaloids modulate cell-mediated cytotoxicity | Bioorganic & Medicinal Chemistry | 2002 |